AOD-9604

AOD-9604

5MG

AOD-9604 is dosed at 300 mcg–500 mcg daily via subcutaneous injection in educational protocols. A 2 mg vial reconstituted with bacteriostatic water yields about 0.667 mg/mL. This information is for research and educational use only.

In stock   |   ≥99% catalog purity

SKU: N/A Category:

Description

Product specification

Analytical Profile

Catalog data is presented for material identification and laboratory planning. Batch-specific documentation governs the supplied vial.

RESEARCH NAMEAOD-9604 · Tyr-hGH Fragment 177–191
FORMATLyophilised powder
MOLECULAR FORMULAC78H123N23O23S2
MOLECULAR MASS1815.1 g/mol
CAS REGISTRY221231-10-3
ANALYTICAL IDENTITYHPLC + LC–MS
CATALOG CONDITIONLyophilised · −20°C

PROTOCOL LITERACY

Reconstitution Sequence

This sequence uses a 2 mg vial reconstituted with 3.0 mL of bacteriostatic water, giving an approximate concentration of 0.667 mg/mL. Follow the supplied product instructions for preparation and storage.

01

prepare

Prepare 1.0 mL of bacteriostatic water with sterile equipment.

02

INTRODUCE SLOWLY

Direct the liquid toward the inside wall of the vial to limit foaming.

03

DISSOLVE GENTLY

Roll or swirl with care until the material is dissolved; do not shake.

04

LABEL AND PROTECT

Record the preparation date and keep the vial protected from light.

05

COLD STORAGE

Refrigerate at 2-8°C and use within the four-week reference window.

UNRECONSTITUTED MATERIAL

-20°C

Keep frozen, dry, sealed, and protected from direct light. Minimise exposure to moisture.

After reconstitution

2-8°C

Keep refrigerated after reconstitution and protect from unnecessary temperature changes.

Handling principle

DO NOT FREEZE

Avoid repeated freeze–thaw cycles and maintain appropriate refrigerated storage after reconstitution.

PROTOCOL LITERACY

AOD-9604 DOSAGE CHART

A source-derived reference covering concentration, gradual daily dosing, reconstitution, storage, and handling context. It is educational material—not an individualized regimen.

VIAL CONTENT

5 MG

+

REFERENCE DILUENT

3.0 MG

=

STOCK CONCENTRATION

1.667 MG/ML

U-100 SCALE

1 UNIT = 0.01 ML = 16.67 MCG

01

GRADUAL 8MG MODEL

02

12 MG TRIAL CONTEXT

EDUCATIONAL REFERENCE

GRADUAL DAILY MODEL

STUDY INTERVALSTAGEWEEKLY DOSEU-100 REFERENCESOLUTION VOLUME
01 WEEKS 1-4
INITIATION300 MG18 UNITS0.18 ML
02 WEEKS 5-12
MAINTENANCE500 MCG30 UNITS0.30 ML

01

REFERENCE ASSUMPTIONS

Every unit and volume value shown assumes a 10 mg vial prepared to a total reference volume of 1.0 mL.

02

MATERIAL BOUNDARY

This table does not provide preparation or administration instructions.

03

PROTOCOL CONTROL

Trial documentation and qualified clinical oversight—not this chart—must govern all dosing decisions.

Related products

Product Enquiry

Have a question about this product? Send us your enquiry and our team will get back to you shortly.

Enquire Product